Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-01-10 @ 2:18 PM
Study NCT ID:
NCT05959356
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-07-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer
Sponsor:
Organization: